Rapid induction of Thy-1 antigenic markers on keratinocytes and epidermal immune cells in the skin of mice following topical treatment with common preservatives used in topical medications and in foods.

Earlier experiments from our laboratory revealed that the medication most commonly used for depigmenting patients with vitiligo, monobenzyl ether of hydroquinone (MBEH), when applied to the skin of DBA/2 mice caused an increase in the population density (cells/mm2) of identifiable Ia+ and ATPase+ Langerhans cells. Further, this increase in Langerhans cell density could be correlated with an increase of contact hypersensitivity (CHS) reactivity to dinitrofluorobenzene (DNFB). The current experiments demonstrated that other compounds chemically similar to MBEH, such as butylated hydroxytoluene (BHT) and butylated hydroxyanisole (BHA), which are used as preservatives/antioxidants in many topical medications, cosmetics, food, and rubber products, can in five days significantly increase the population density of Thy-1+ dendritic epidermal cells. These compounds had no effects on Ia+ cells. This observation suggests that the Thy-1+ DEC cells may be more mobile and/or their surface markers may be readily expressed and are not a slowly mobile (trafficking) population of cells as suggested by the results of previous work. In addition, these parasubstituted phenolic compounds behaved like pertussis toxin and induced Thy-1 and Ia expression on keratinocytes. These changes in Thy-1 immune markers were not accompanied by functional alterations in the immune response to contact allergens as measured by the ear swelling technique.

[1]  D. Stephany,et al.  Culture and characterization of murine dendritic Thy-1+ epidermal cells. , 1986, The Journal of investigative dermatology.

[2]  J. Nordlund,et al.  Modulation of the population density of identifiable epidermal Langerhans cells associated with enhancement or suppression of cutaneous immune reactivity. , 1986, Journal of immunology.

[3]  G. Krueger,et al.  Correlation between keratinocyte expression of Ia and the intensity and duration of contact hypersensitivity responses in mice. , 1985, Journal of immunology.

[4]  K. Wolff,et al.  Morphological and phenotypical characterization of bone marrow-derived dendritic Thy-1-positive epidermal cells of the mouse. , 1985, The Journal of investigative dermatology.

[5]  D. A. Chambers The Thy‐I epidermal cell: perspective and prospective , 1985, The British journal of dermatology.

[6]  J. Streilein,et al.  Origin and function of Thy-1+ dendritic epidermal cells in mice. , 1985, The Journal of investigative dermatology.

[7]  G. Krueger,et al.  Correlation between the inducible keratinocyte expression of Ia and the movement of Langerhans cells into the epidermis. , 1985, Journal of immunology.

[8]  R. Steinman,et al.  The Thy-1-bearing cell of murine epidermis. A distinctive leukocyte perhaps related to natural killer cells , 1985, The Journal of experimental medicine.

[9]  J. Streilein,et al.  Thy-1 antigen-bearing dendritic cells in murine epidermis are derived from bone marrow precursors. , 1984, The Journal of investigative dermatology.

[10]  T. Merigan,et al.  Recombinant gamma interferon induces HLA-DR expression on cultured human keratinocytes. , 1984, The Journal of investigative dermatology.

[11]  G. Krueger,et al.  Biology of Langerhans cells: analysis by experiments to deplete Langerhans cells from human skin. , 1984, The Journal of investigative dermatology.

[12]  C. Janeway,et al.  Quantitative variation in la antigen expression plays a central role in immune regulation. , 1984, Immunology today.

[13]  J. Dees,et al.  Thy-1 antigen-bearing dendritic cells populate murine epidermis. , 1983, The Journal of investigative dermatology.

[14]  K. Wolff,et al.  Expression of Thy-1 antigen by murine epidermal cells. , 1983, The Journal of investigative dermatology.

[15]  D. Mason,et al.  Immunology: Graft rejection and Ia antigens — paradox resolved? , 1983, Nature.

[16]  H. Babich,et al.  Butylated hydroxytoluene (BHT): a review. , 1982, Environmental research.

[17]  V. Morhenn,et al.  Expression of HLA-DR antigen in skin from patients with psoriasis. , 1982, The Journal of investigative dermatology.

[18]  G. Stingl,et al.  Origin and Function of Epidermal Langerhans Cells , 1980, Immunological reviews.

[19]  G. Thorbecke,et al.  Contact hypersensitivity and Langerhans cells. , 1980, The Journal of investigative dermatology.

[20]  J. Wess,et al.  Chemical dissection of the primary and secondary in vitro antibody responses with butylated hydroxyanisole and gallic acid. , 1979, Drug and chemical toxicology.

[21]  D. Archer,et al.  Suppression of Macrophage-Dependent T-Lymphocyte Function(s) by Gallic Acid, a Food Additive Metabolite , 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[22]  D. Archer,et al.  Inhibitory Effect of an Anti-oxidant, Butylated Hydroxyanisole, on the Primary in Vitro Immune Response , 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[23]  G. Thorbecke,et al.  Dermal and intravascular Langerhans cells at sites of passively induced allergic contact sensitivity. , 1975, Cellular immunology.

[24]  I. Silberberg Apposition of mononuclear cells to langerhans cells in contact allergic reactions. An ultrastructural study. , 1973, Acta dermato-venereologica.

[25]  L. Old,et al.  SEROLOGICALLY DEMONSTRABLE ALLOANTIGENS OF MOUSE EPIDERMAL CELLS , 1972, The Journal of experimental medicine.